GlassScriptPhysician profile
Monte Swarup
NPI 1790762094
$8,181.38
in general payments reported to CMS, 2019-2025
40 companies · $311 in 2025
The $311 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,702 · 2020: $181 · 2021: $2,027 · 2022: $780 · 2023: $756 · 2024: $424 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,491.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $3,340.63 | 2019 | |
| Hologic Sales and Service, LLC | $2,357.66 | 2019-2025 | Myosure Tissue Removal Device, Acessa Provu System, Novasure |
| Abbvie INC. | $379.79 | 2019-2023 | Liletta |
| Bayer Healthcare Pharmaceuticals INC. | $331.35 | 2020-2025 | |
| Coopersurgical, INC. | $233.76 | 2019-2024 | Paragard T 380a, Paragard T 380a, Advincula Delineator Uterine Manipulator |
| Gynesonics, INC. | $120.22 | 2022-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Pfizer INC. | $117.97 | 2023-2025 | |
| Astellas Pharma US INC | $103.44 | 2023-2025 | Veozah |
| Medtronic, INC. | $100.22 | 2022-2025 | Interstim, Venaseal |
| Alydia Health | $99.23 | 2021 | |
| Biogen, INC. | $98.74 | 2024-2025 | Zurzuvae |
| Organon LLC | $83.18 | 2022-2025 | Nexplanon |
| Daiichi Sankyo INC. | $73.57 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $63.45 | 2022-2023 | |
| Ethicon US, LLC | $60.68 | 2019-2024 | Enseal X1 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $57.09 | 2020-2024 | Ova1 |
| Myovant Sciences INC. | $56.84 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $47.12 | 2019-2024 | Gardasil 9, Gardasil |
| Channel Medsystems, INC. | $42.50 | 2022 | |
| Axonics, INC. | $39.54 | 2022-2023 | Axonics |
| Shield Therapeutics INC | $36.54 | 2025 | |
| Minerva Surgical, INC | $33.82 | 2019 | |
| Agile Therapeutics, INC. | $31.96 | 2021-2023 | Twirla |
| Mylan Pharmaceuticals INC. | $30.47 | 2021 | |
| Exeltis, USA INC. | $27.53 | 2021-2022 | |
| Meditrina | $26.29 | 2022-2025 | |
| Roche Diagnostics Corporation | $21.86 | 2019 | |
| Ibsa Pharma INC. | $21.27 | 2024 | Licart, Tirosint |
| Abbott Laboratories | $17.75 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.74 | 2022 | |
| Dexcom, INC. | $17.43 | 2025 | Dexcom G6 Transmitter |
| Kci USA, INC. | $15.63 | 2020 | |
| Evofem Biosciences, INC. | $15.13 | 2021 | |
| Smith+Nephew, INC. | $13.78 | 2025 | Pico 7, Pico 14 |
| Becton, Dickinson and Company | $13.50 | 2025 | Bd Onclarity |
| Sage Therapeutics, LLC | $11.89 | 2022 | |
| Lupin INC. | $11.52 | 2019 | |
| Monaghan Medical Corporation | $10.29 | 2023 | Aeroeclipse |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monte Swarup listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.